CTSA Pharmaceutical Assets Portal

The purpose of the CTSA Pharmaceutical Assets Portal is to forge
relationships with the pharmaceutical/biotech industry with the
intent to facilitate the transfer of the investigational drugs and
biologics for academic research.

 

The Portal would be used to "match" academic research with
pharmaceutical assets that may be useful in elucidating disease
mechanisms or for discovery of new uses in clinical treatment.
How does it work?
*****

The Portal is sponsored by Clinical and Translational Sciences Award from NCRR, and supported by the efforts of:

University of California in Davis
Oregon Health and Sciences University
University of Washington (Seattle)

 

Recent News:

 

The Portal in Nature Medicine, January 2010: Matchmaking service links up researchers to wallflower drugs

 

January 2010. European Molecular Biology Laboratory's European Bioinformatics Institute launches ChEMBL is a database of 500,000 bioactive compounds, their quantitative properties and bioactivities (binding constants, pharmacology and ADMET, etc). The data is abstracted and curated from the primary scientific literature and the data made available due to funding by the Wellcome Trust. You can search available compounds based on the target and view the detailed ChEBI Compound ID.

http://www.ebi.ac.uk/chembldb/index.php/target


CTSA Pharmaceutical Assest Portal is highlited on the NIH Forecast Report to the Office of the Secretary of Health and Human Services


The National Center for Research Resources along with the National Cancer Institute and the Clinical Center at the National Institutes of Health present:
CTSA Pharmaceutical Assets Portal: Matching Academia and Industry for Drug Repositioning
Friday, December 4, 2009
9:00 a.m. – noon
Lipsett Amphitheater, Building 10, NIH Campus, Bethesda, MD
View Agenda


CTSA Presents the Portal Project at the annual Drug Repositioning Summit in Boston, October 14, 2009
(download PDF of the presentation)


CTSA Pharma Portal in Proto Magazine, July 2009


Read about the Portal Project in the CTSA Newsletter, March 2,
2009


Biovista delivers critical data for the CTSA Pharmaceutical Assets
Portal


European Bioinformatics Institute Makes Galapagos
Chemogenomic Database Publicly Available with $9.38M Grant


CTSA presents the Portal Project at the Third Annual Drug
Repositioning Summit in Boston,
October 2008 (download PDF)